These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15011248)

  • 1. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
    Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; MusarĂ² A; Bannister RA
    Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Sharp PS; Dick JR; Greensmith L
    Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model.
    Hayworth CR; Gonzalez-Lima F
    Neuroscience; 2009 Dec; 164(3):975-85. PubMed ID: 19699279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
    Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
    J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
    Mead RJ; Bennett EJ; Kennerley AJ; Sharp P; Sunyach C; Kasher P; Berwick J; Pettmann B; Battaglia G; Azzouz M; Grierson A; Shaw PJ
    PLoS One; 2011; 6(8):e23244. PubMed ID: 21876739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Turner BJ; Lopes EC; Cheema SS
    Neurosci Lett; 2003 Oct; 350(2):132-6. PubMed ID: 12972170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Hegedus J; Putman CT; Tyreman N; Gordon T
    J Physiol; 2008 Jul; 586(14):3337-51. PubMed ID: 18467368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
    Turner BJ; Lopes EC; Cheema SS
    J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
    Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
    Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
    Gong YH; Elliott JL
    Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-carnitine suppresses the onset of neuromuscular degeneration and increases the life span of mice with familial amyotrophic lateral sclerosis.
    Kira Y; Nishikawa M; Ochi A; Sato E; Inoue M
    Brain Res; 2006 Jan; 1070(1):206-14. PubMed ID: 16412993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS.
    Hatzipetros T; Kidd JD; Moreno AJ; Thompson K; Gill A; Vieira FG
    J Vis Exp; 2015 Oct; (104):. PubMed ID: 26485052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis.
    Galbiati M; Onesto E; Zito A; Crippa V; Rusmini P; Mariotti R; Bentivoglio M; Bendotti C; Poletti A
    Pharmacol Res; 2012 Feb; 65(2):221-30. PubMed ID: 22178654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice.
    David G; Nguyen K; Barrett EF
    Exp Neurol; 2007 Mar; 204(1):411-20. PubMed ID: 17292357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.